Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Meryl Bartlett

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
FDA, FDA matters, FDA regulatory
Office
Washington, D.C.
Active in the record
2021 to 2026

Deal experience

Deal types
Capital Markets & IPODebt Capital MarketsM&APrivate Equity & Buyouts
Sectors
Agriculture & FoodConsumer & RetailFinancial ServicesHealthcare & Life SciencesIndustrials & Manufacturing
Jurisdictions
GermanyNorth AmericaSpainTexasUnited KingdomUnited States

Recent deals

15 announced deals in the record
Latham Represents Warburg Pincus in Agreement to Invest Up to US$1 Billion in Global Eggs 6 Mar 2026
Private Equity & Buyouts Agriculture & Food Latham & Watkins LLP USD 1bn FDA matters
Latham Advises CVC on Sale of Minority Stake in Rayner 10 Feb 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP EUR 500m healthcare and life sciences Washington, D.C.
Latham & Watkins Advises Precision Concepts International in Acquisition of Comar 8 Nov 2025
M&A Industrials & Manufacturing Latham & Watkins LLP FDA regulatory
Latham & Watkins Advises Clario in US$8.875 Billion Sale to Thermo Fisher Scientific 4 Nov 2025
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 8.88bn FDA regulatory
Latham & Watkins Advises on Gilead Sciences’ US$3.5 Billion Senior Unsecured Notes Offering 21 Nov 2024
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 3.50bn FDA regulatory
Latham & Watkins Advises PROCEPT BioRobotics on Offering of Common Stock 3 Nov 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 175m regulatory
Latham & Watkins Advises SLR Capital on Completed Vapotherm Merger and Take-Private 28 Sept 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 83m FDA regulatory
Latham & Watkins Advised on Liquidia Corporation’s Common Stock Financing 12 Sept 2024
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 67.5m FDA
Latham & Watkins Advises Platinum Equity in Acquisition of GSM Outdoors 23 Jul 2024
M&A Consumer & Retail Latham & Watkins LLP FDA regulatory
Latham & Watkins Advises Invetx in Acquisition by Dechra Pharmaceuticals 19 Jul 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 520m FDA regulatory
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Meryl Bartlett is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 15 deals for Meryl Bartlett

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction